Physician

Rachel Lauren Gross, M.D.

According to 2025 Medicare claims, Rachel Gross, M.D. (NPI: 1811157522) practices rheumatology in the Boston, MA market, with the plurality of this provider's patient population coming from Plymouth, MA. This provider's primary affiliated billing organization is ATRIUS HEALTH, INC. (NPI: 1871639914; TIN: 043397450) and primary practice location at 02360-2677. Gross is affiliated with the Mass General Brigham ACO, LLC (ACO ID: A4641) and Atrius Health, Inc. (ACO ID: A5088), participating under the MSSP model.

Gross' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 891 traditional Medicare patients, billed 99,955 HCPCS/CPT codes, and received $724,841 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 4,983 prescription claims across 722 beneficiaries totaling $6,705,290 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 1 records totaling $15. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $964,259 to $6,705,290. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	971	48,996	$636,005
2016	841	61,122	$698,832
2017	1,116	39,628	$506,559
2018	992	39,757	$425,348
2019	908	50,821	$586,698
2020	841	38,524	$461,437
2021	931	71,199	$707,519
2022	909	83,353	$646,906
2023	884	90,459	$659,809
2024	891	99,955	$724,841

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	369	2,774	$964,259
2016	406	3,014	$1,146,613
2017	495	3,970	$1,439,506
2018	619	4,595	$2,023,056
2019	571	4,311	$2,714,366
2020	613	4,310	$3,871,641
2021	706	4,354	$4,381,371
2022	699	4,690	$5,601,283
2023	685	4,606	$6,136,970
2024	722	4,983	$6,705,290

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	619	1,046	$90
36415	Insertion of needle into vein for collection of blood sample	578	1,182	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	281	613	$8
86140	Measurement c-reactive protein for detection of infection or inflammation	339	636	$5
82565	Blood creatinine level	433	825	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	154	4,708	$1,250,035
Enbrel Sureclick	Etanercept	118	3,920	$949,440
Taltz Autoinjector	Ixekizumab	70	2,084	$572,070
Otezla	Apremilast	84	2,518	$367,817
Rinvoq	Upadacitinib	58	1,740	$359,703

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$15	Sandoz Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Rachel Lauren Gross, M.D.?

Tedicare shows public-source Medicare data for Rachel Lauren Gross, M.D. (NPI 1811157522), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rachel Lauren Gross, M.D. have ACO affiliation data?

Rachel Lauren Gross, M.D. is shown with ACO affiliation data for Mass General Brigham ACO, LLC (MSSP, ACO ID A4641) and Atrius Health, Inc. (MSSP, ACO ID A5088).

What billing organization is linked to Rachel Lauren Gross, M.D.?

Rachel Lauren Gross, M.D. is linked to ATRIUS HEALTH, INC. (billing NPI 1871639914) in the available physician profile data.

Does Rachel Lauren Gross, M.D. have Open Payments data?

Rachel Lauren Gross, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.